Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Sep 19, 2013 vagelos p roy Officer Automatic Sell 145,356 300.34 - 310.18
Sep 18, 2013 roberts william Officer Automatic Sell 15,000 304.00
Sep 18, 2013 roberts william Officer Option Execute 15,000 16.80
Sep 18, 2013 schleifer leonard s Officer Automatic Sell 115,440 304.38
Sep 18, 2013 schleifer leonard s Officer Option Execute 218,389 9.49
Sep 18, 2013 vagelos p roy Officer Automatic Sell 167,144 304.38
Sep 18, 2013 vagelos p roy Officer Option Execute 312,500 13.00
Sep 18, 2013 van plew daniel p Officer Automatic Sell 23,977 298.28 - 308.26
Sep 17, 2013 van plew daniel p Officer Automatic Sell 28,523 294.75
Sep 17, 2013 van plew daniel p Officer Option Execute 52,500 16.80
Sep 9, 2013 landry robert e Officer Acquisition (Non Open Market) 5,000 n/a
Sep 9, 2013 schleifer leonard s Officer Automatic Buy 5,000 n/a
Sep 9, 2013 schleifer leonard s Officer Automatic Sell 5,000 275.04 - 277.12
Aug 23, 2013 goldstein joseph l Director Sell 1,000 238.29
Aug 23, 2013 ryan arthur f Director Sell 10,958 238.47
Aug 22, 2013 ryan arthur f Director Disposition (Non Open Market) 4,042 236.64
Aug 22, 2013 ryan arthur f Director Option Execute 30,000 18.61 - 57.11
Aug 14, 2013 goldstein joseph l Director Acquisition (Non Open Market) 5,000 n/a
Aug 1, 2013 goldberg murray a Officer Option Execute 5,000 16.80
Jul 5, 2013 vagelos p roy Officer Disposition (Non Open Market) 921 n/a
Showing 181-200 of 841 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)